Human Immunodeficiency Virus and Hepatitis C Virus: Which Is the Cart, and Which Is the Horse?

Jenny-Avital, Elizabeth R.
September 2003
Clinical Infectious Diseases;9/1/2003, Vol. 37 Issue 5, p739
Academic Journal
Focuses on HIV and Hepatitis C Virus. Acceleration of Hepatitis C Virus by HIV-induced immunosuppression; Relation between the duration of Hepatitis C Virus infection and fibrosis progression rate.


Related Articles

  • Review of the Effect of Highly Active Antiretroviral Therapy on Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus and HCV Coinfection. Cooper, Curtis L.; Cameron, D. William // Clinical Infectious Diseases;10/1/2002, Vol. 35 Issue 7, p873 

    Describes the apparent effect of antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Systematic and biologic variation of HCV RNA level.

  • Liver Damage and Kinetics of Hepatitis C Virus and Human Immunodeficiency Virus Replication during the Early Phases of Combination Antiretroviral Treatment. Puoti, Massimo; Gargiulo, Francesco; Roldan, Eugenia Quiros; Chiodera, Alessandro; Palvarini, Loredana; Spinetti, Angiola; Zaltron, Serena; Putzolu, Valeria; Zanini, Barbara; Favilli, Flavia; Turano, Adolfo; Carosi, Giampiero // Journal of Infectious Diseases;6/1/2000, Vol. 181 Issue 6, p2033 

    Assesses the liver damage and kinetics of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) replication during the early phases of combination antiretroviral treatment. Evolution of HCV RNA, HIV RNA, CD4 and CD8 cell counts and alanine aminotransferase levels during combination...

  • Hepatitis C in the Setting of HIV. Laurence, Jeffrey // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p595 

    Editorial. Discusses the special character of hepatitis C virus (HCV) disease in the setting of human immunodeficiency virus (HIV). Etiologic link between HCV and several serious diseases; Classification of HCV; Symptoms of HCV infection; Information on the management of HCV; Recommendation...

  • HAART AND HCV INFECTION.  // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p646 

    Reports that a study found that highly active antiretroviral therapy (HAART) does not affect hepatitis C virus (HCV) progression in patients who have coinfection with the human immunodeficiency virus (HIV) and HCV. Who monitored HCV progression in 22 patients; Information on study.

  • Immunosuppression May Lead to Progression of Hepatitis C Virus-Associated Liver Disease in Hemophiliacs Coinfected with HIV. Rockstroh, J. K.; Spengler, U.; Sudhop, T.; Ewig, S.; Theisen, A.; Hammerstein, U.; Bierhoff, E.; Fischer, H. P.; Oldenburg, J.; Brackmann, H. H.; Sauerbruch, T. // American Journal of Gastroenterology;Dec1996, Vol. 91 Issue 12, p2563 

    Objective: The aim of this study was to examine the interaction between HIV and hepatitis C virus (HCV) in hemophiliacs coinfected with the viruses and to investigate the possible relationship between immunosuppression and liver failure. Methods: To identify risk factors for impending liver...

  • Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus. Mildvan, Donna // Clinical Infectious Diseases;11/15/2003 Supplement, Vol. 37, pS293 

    Anemia is a multifactorial problem in patients with human immunodeficiency virus (HIV) infection, cancer, and hepatitis C virus (HCV) infection. New insights regarding anemia symptoms and quality of life (QOL) have prompted reassessment of traditional triggers for anemia treatment to increase...

  • Comparison of Methodologies for Quantification of Hepatitis C Virus (HCV) RNA in Patients Coinfected with HCV and Human Immunodeficiency Virus. Sherman, Kenneth E.; Rouster, Susan D.; Horn, Paul S. // Clinical Infectious Diseases;8/15/2002, Vol. 35 Issue 4, p482 

    Quantification of hepatitis C virus (HCV) RNA is important in the assessment of HCV-associated liver disease in patients coinfected with HCV and human immunodeficiency virus (HIV). To investigate whether the standard integrity of competing test methodologies might be compromised by higher HCV...

  • A 50 year old man with progressive cough and exertional dyspnea. Bhatti, Hammad; Usman, Faisal // International Journal of Critical Illness & Injury Science;Jan-Mar2013, Vol. 3 Issue 1, p93 

    A letter to the editor about a case report of a 50-year-old male patient with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and who experienced an organizing pneumonia (OP), is presented.

  • Saskatchewan Agrees to Cover New HCV and HIV Drugs. Procyk, Roger // Canadian HIV/AIDS Policy & Law Review;Aug2003, Vol. 8 Issue 2, p28 

    Reports on the agreement of the Saskatchewan government to cover the new hepatitis C virus and HIV drugs Pegetron and Valcyte as of August 2003. Terms under the Exceptional Drug Status program; Criterion for obtaining special support status; Information on the drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics